Article Details
Retrieved on: 2023-01-09 10:33:23
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
AstraZeneca said on Monday it has struck a deal to buy U.S.-based biopharmaceutical firm CinCor Pharma Inc for up to $1.8 billion to strengthen ...
Article found on: financialpost.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here